Thrombotic antiphospholipid syndrome: A practical guide to diagnosis and management

Link to article at PubMed

Thromb Res. 2020 Oct 15;198:213-221. doi: 10.1016/j.thromres.2020.10.010. Online ahead of print.


Thrombotic antiphospholipid syndrome (APS) is characterised by venous, arterial and/or small vessel thrombosis in the context of persistently positive antiphospholipid antibodies (aPL). The diagnosis and management of thrombotic APS continues to prove challenging for clinicians. We provide a practical guide to the diagnosis of APS including who to test for aPL and which tests to do. We also consider clinical practice points on the management of venous, arterial and small vessel thrombosis, in the context of first and recurrent thrombotic events. Non-criteria manifestations of APS are reviewed. An approach to recurrent thrombosis and anticoagulant-refractory APS is discussed, with options including increasing the anticoagulation intensity of vitamin K antagonists, switching to low-molecular-weight-heparin, the use of fondaparinux and/or the addition of antiplatelet treatment. Adjunctive options such as vitamin D, hydroxychloroquine and statins are also addressed.

PMID:33485122 | PMC:PMC7560059 | DOI:10.1016/j.thromres.2020.10.010

Leave a Reply

Your email address will not be published. Required fields are marked *